HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers

References

• Zou J, Cao Z, Zhang J, Chen T, Yang S, Huang Y, Hong D, Li Y, Chen X, Wang X, et al. Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix. Oncotarget 2016; 7:40135-47; PMID:27223085; https://doi.org/10.18632/oncotarget.9510
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12:418-24; PMID:6325356; https://doi.org/10.1016/S0300-9785(83)80033-7
   PubMedGoogle Scholar
• Al-Bakkal G, Ficarra G, McNeill K, Eversole LR, Sterrantino G, Birek C. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87:197-208; PMID:10052376; https://doi.org/10.1016/S1079-2104(99)70273-8
   PubMed Web of Science ®Google Scholar
• Terai M, Burk RD. Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia. J Gen Virol 2001; 82:2035-40; PMID:11514712; https://doi.org/10.1099/0022-1317-82-9-2035
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-75; PMID:15734974; https://doi.org/10.1158/1055-9965.EPI-04-0551
   PubMed Web of Science ®Google Scholar
• Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. Bioessays 1995; 17:97-9; PMID:7748170; https://doi.org/10.1002/bies.950170203
   PubMed Web of Science ®Google Scholar
• Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994; 54:3544-52; PMID:8012979
   PubMed Web of Science ®Google Scholar
• Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 1996; 10:1443-54; PMID:8666229; https://doi.org/10.1101/gad.10.12.1443
   PubMed Web of Science ®Google Scholar
• Peifer M. Beta-catenin as oncogene: the smoking gun. Science 1997; 275:1752-3; PMID:9122680; https://doi.org/10.1126/science.275.5307.1752
   PubMed Web of Science ®Google Scholar
• Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998; 186:8-16; PMID:9875134; https://doi.org/10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Williams HK, Sanders DS, Jankowski JA, Landini G, Brown AM. Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 1998; 27:308-17; PMID:9725568; https://doi.org/10.1111/j.1600-0714.1998.tb01962.x
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF, De Rosa G. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 1999; 19:3817-26; PMID:10628318
   PubMed Web of Science ®Google Scholar
• Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W. E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol 2005; 3:38; PMID:15969753; https://doi.org/10.1186/1477-7819-3-38
   PubMedGoogle Scholar
• Uren A, Fallen S, Yuan H, Usubütün A, Küçükali T, Schlegel R, Toretsky JA. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 2005; 65:6199-206; PMID:16024621; https://doi.org/10.1158/0008-5472.CAN-05-0455
   PubMed Web of Science ®Google Scholar
• Soares CP, Benatti Neto C, Fregonezi PA, Teresa DB, Santos RT, Longatto Filho A, Maeda MY. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus. Anal Quant Cytol Histol 2003; 25:19-24; PMID:12630078
   PubMedGoogle Scholar
• Zhao M, Kim YT, Yoon BS, Kim SW, Kang MH, Kim SH, Kim JH, Kim JW, Park YW. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol 2006; 28:44-8; PMID:16614707
   PubMedGoogle Scholar
• Leung TW, Xue WC, Cheung AN, Khoo US, Ngan HY. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix. Gynecol Oncol 2004; 92:866-72; PMID:14984954; https://doi.org/10.1016/j.ygyno.2003.11.051
   PubMed Web of Science ®Google Scholar
• Barton GM. Viral recognition by Toll-like receptors. Semin Immunol 2007; 19:33-40; PMID:17336545; https://doi.org/10.1016/j.smim.2007.01.003
   PubMed Web of Science ®Google Scholar
• Sogabe Y, Suzuki H, Toyota M, Ogi K, Imai T, Nojima M, Sasaki Y, Hiratsuka H, Tokino T. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. Int J Oncol 2008; 32:1253-61; PMID:18497987; https://doi.org/10.3892/ijo.32.6.1253
   PubMed Web of Science ®Google Scholar
• Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A, et al. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 2010; 24:1035-41; PMID:20811686; https://doi.org/10.3892/or_00000952
   PubMed Web of Science ®Google Scholar
• Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37:766-70; PMID:15965474; https://doi.org/10.1038/ng1590
   PubMed Web of Science ®Google Scholar
• Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120:21-4; PMID:15652478; https://doi.org/10.1016/j.cell.2004.12.031
   PubMed Web of Science ®Google Scholar
• Kämper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, Hilbig L, Schiller JT, Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 2006; 80:759-68; PMID:16378978; https://doi.org/10.1128/JVI.80.2.759-768.2006
   PubMed Web of Science ®Google Scholar
• Shi TY, Cheng X, Yu KD, Sun MH, Shao ZM, Wang MY, Zhu ML, He J, Li QX, Chen XJ, et al. Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis 2013; 34:770-8; PMID:23299407; https://doi.org/10.1093/carcin/bgt001
   PubMed Web of Science ®Google Scholar
• Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 2003; 77:12450-9; PMID:14610169; https://doi.org/10.1128/JVI.77.23.12450-12459.2003
   PubMed Web of Science ®Google Scholar
• Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69:2989-97; PMID:7707525
   PubMed Web of Science ®Google Scholar
• Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995; 92:1654-8; PMID:7878034; https://doi.org/10.1073/pnas.92.5.1654
   PubMed Web of Science ®Google Scholar
• Flores ER, Lambert PF. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol 1997; 71:7167-79; PMID:9311789
   PubMed Web of Science ®Google Scholar
• Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004; 78:12762-72; PMID:15542628; https://doi.org/10.1128/JVI.78.23.12762-12772.2004
   PubMed Web of Science ®Google Scholar
• Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC, Kalantari M, Calleja-Macias IE, Bernard HU, Garcia-Carranca A. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 2007; 120:2165-9; PMID:17278110; https://doi.org/10.1002/ijc.22563
   PubMed Web of Science ®Google Scholar
• Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU. Human papillomavirus-16 and −18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer 2008; 123:1832-40; PMID:18688866; https://doi.org/10.1002/ijc.23707
   PubMed Web of Science ®Google Scholar
• Kalantari M, Chase DM, Tewari KS, Bernard HU. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. J Med Virol 2010; 82:311-20; PMID:20029805; https://doi.org/10.1002/jmv.21676
   PubMed Web of Science ®Google Scholar
• Kalantari M, Garcia-Carranca A, Morales-Vazquez CD, Zuna R, Montiel DP, Calleja-Macias IE, Johansson B, Andersson S, Bernard HU. Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 2009; 390:261-7; PMID:19497607; https://doi.org/10.1016/j.virol.2009.05.006
   PubMed Web of Science ®Google Scholar
• Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK, Martel M, Harigopal M, Schofield K, Neapolitano M. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009; 389:100-7; PMID:19443004; https://doi.org/10.1016/j.virol.2009.03.029
   PubMed Web of Science ®Google Scholar
• Popescu NC, DiPaolo JA. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res 1990; 50:1316-23; PMID:2153457
   PubMed Web of Science ®Google Scholar
• Smith PP, Friedman CL, Bryant EM, McDougall JK. Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes Chromosomes Cancer 1992; 5:150-7; PMID:1381951; https://doi.org/10.1002/gcc.2870050209
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9:775-89; PMID:20885409; https://doi.org/10.1038/nrd3179
   PubMed Web of Science ®Google Scholar
• Ji W, Sun B, Su C. Targeting MicroRNAs in Cancer Gene Therapy. Genes (Basel) 2017; 8:E21; PMID:28075356; https://doi.org/10.3390/genes8010021
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao LJ, Liang WQ, Mao ZP. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis. Genet Mol Res 2015; 14:16562-76; PMID:26681002; https://doi.org/10.4238/2015.December.11.3
   PubMed Web of Science ®Google Scholar
• Irani S. miRNAs Signature in Head and neck squamous cell carcinoma metastasis: A literature review. J Dent (Shiraz) 2016; 17:71-83; PMID:27284551
   PubMedGoogle Scholar
• Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. J Hum Genet 2017; 62:3-13; PMID:27557665; https://doi.org/10.1038/jhg.2016.105
   PubMed Web of Science ®Google Scholar
• Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, Rose B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007; 358:12-7; PMID:17475218; https://doi.org/10.1016/j.bbrc.2007.03.201
   PubMed Web of Science ®Google Scholar
• Gomes CC, Gomez RS. MicroRNA and oral cancer: future perspectives. Oral Oncol 2008; 44:910-4; PMID:18620891; https://doi.org/10.1016/j.oraloncology.2008.01.002
   PubMed Web of Science ®Google Scholar
• Guan X, Liu Z, Liu H, Yu H, Wang LE, Sturgis EM, Li G, Wei Q. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J 2013; 27:1404-12; PMID:23271051; https://doi.org/10.1096/fj.12-223420
   PubMed Web of Science ®Google Scholar
• Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, Marsit CJ, Kelsey KT. A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009; 30:1003-7; PMID:19380522; https://doi.org/10.1093/carcin/bgp099
   PubMed Web of Science ®Google Scholar
• Chawla JP, Iyer N, Soodan KS, Sharma A, Khurana SK, Priyadarshni P. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer. Oral Oncol 2015; 51:731-7; PMID:26093389;https://doi.org/10.1016/j.oraloncology.2015.05.008
   PubMed Web of Science ®Google Scholar
• Vojtechova Z, Sabol I, Salakova M, Smahelova J, Zavadil J, Turek L, Grega M, Klozar J, Prochazka B, Tachezy R. Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. BMC Cancer 2016; 16:382; PMID:27377959; https://doi.org/10.1186/s12885-016-2430-y
   PubMed Web of Science ®Google Scholar
• Gasche JA, Goel A. Epigenetic mechanisms in oral carcinogenesis. Future Oncol 2012; 8:1407-25; PMID:23148615; https://doi.org/10.2217/fon.12.138
   PubMed Web of Science ®Google Scholar
• Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, De Rosa G, Staibano S. Epigenetic disregulation in oral cancer. Int J Mol Sci 2012; 13:2331-53; PMID:22408457; https://doi.org/10.3390/ijms13022331
   PubMed Web of Science ®Google Scholar
• Cuesta Gil M, Bucci T, Navarro Cuellar C, Duarte Ruiz B, Pannone G, Bufo P, Navarro Vila C. Intraosseous myoepithelioma of the maxilla: clinicopathologic features and therapeutic considerations. J Oral Maxillofac Surg 2008; 66:800-3; PMID:18355609; https://doi.org/10.1016/j.joms.2007.06.002
   PubMed Web of Science ®Google Scholar
• Pannone G, Rodolico V, Santoro A, Lo Muzio L, Franco R, Botti G, Aquino G, Pedicillo MC, Cagiano S, Campisi G, et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer 2012; 7:4; PMID:22376902; https://doi.org/10.1186/1750-9378-7-4
   PubMed Web of Science ®Google Scholar
• Wilting SM, Miok V, Jaspers A, Boon D, Sørgård H, Lando M, Snoek BC, van Wieringen WN, Meijer CJ, Lyng H, et al. Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence. Oncotarget 2016; 7:43805-19; PMID:27270309; https://doi.org/10.18632/oncotarget.9698
   PubMed Web of Science ®Google Scholar
• Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010; 31:864-70; PMID:20197299; https://doi.org/10.1093/carcin/bgq051
   PubMed Web of Science ®Google Scholar
• Roychowdhury A, Samadder S, Islam MS, Chaudhury K, Roy A, Banerjee D, Mandal R, Basu PS, Roychoudhury S, Panda CK. Identification of changes in the human papilloma virus 16 (HPV16) genome during early dissemination of cervical cancer cells may complement histological diagnosis of lymph node metastasis. Pathol Oncol Res 2017; PMID:28101801; https://doi.org/10.1007/s12253-017-0189-3
   PubMed Web of Science ®Google Scholar
• Bahrami A, Aledavoud SA, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A. The Prognostic and Therapeutic Application of microRNAs in Breast Cancer: Tissue and Circulating microRNAs. J Cell Physiol 2017; PMID:28109133; https://doi.org/10.1002/jcp.25813
   PubMed Web of Science ®Google Scholar
• Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA. MicroRNA expression variability in human cervical tissues. PLoS One 2010; 5:e11780; PMID:20668671; https://doi.org/10.1371/annotation/2ae645ec-9413-4f7d-b51f-eb0678fa2f1b
   PubMed Web of Science ®Google Scholar
• Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012; 11:2876-84; PMID:22801550; https://doi.org/10.4161/cc.21278
   PubMed Web of Science ®Google Scholar
• Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008; 14:2535-42; PMID:18451214; https://doi.org/10.1158/1078-0432.CCR-07-1231
   PubMed Web of Science ®Google Scholar
• He Y, Lin J, Ding Y, Liu G, Luo Y, Huang M, Xu C, Kim TK, Etheridge A, Lin M, et al. A systematic study on dysregulated microRNAs in cervical cancer development. Int J Cancer 2016; 138:1312-27; PMID:26032913; https://doi.org/10.1002/ijc.29618
   PubMed Web of Science ®Google Scholar
• Zhao S, Yao D, Chen J, Ding N, Ren F. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. PLoS One 2015; 10:e0120905; PMID:25803820; https://doi.org/10.1371/journal.pone.0120905
   PubMed Web of Science ®Google Scholar
• Bumrungthai S, Ekalaksananan T, Evans MF, Chopjitt P, Tangsiriwatthana T, Patarapadungkit N, Kleebkaow P, Luanratanakorn S, Kongyingyoes B, Worawichawong S, et al. Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues. PLoS One 2015; 10:e0127109; PMID:26010154; https://doi.org/10.1371/journal.pone.0127109
   PubMed Web of Science ®Google Scholar
• Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K, Aoki D. MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment. ScientificWorldJournal 2014; 2014:178075; PMID:24516357; https://doi.org/10.1155/2014/178075
   PubMedGoogle Scholar
• Gocze K, Gombos K, Juhasz K, Kovacs K, Kajtar B, Benczik M, Gocze P, Patczai B, Arany I, Ember I. Unique microRNA expression profiles in cervical cancer. Anticancer Res 2013; 33:2561-7; PMID:23749909
   PubMed Web of Science ®Google Scholar
• Harden ME, Prasad N, Griffiths A, Munger K. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins. MBio 2017; 8:e02170-16; PMID:28049151 https://doi.org/10.1128/mBio.02170-16
   PubMed Web of Science ®Google Scholar
• Li J, Liu Q, Clark LH, Qiu H, Bae-Jump VL, Zhou C. Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use. Future Oncol 2017; 13(8):743-53; PMID:27806630; https://doi.org/10.2217/fon-2016-0328
   PubMed Web of Science ®Google Scholar
• Li B, Hu Y, Ye F, Li Y, Lv W, Xie X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 2010; 20:597-604; PMID:20442590; https://doi.org/10.1111/IGC.0b013e3181d63170
   PubMed Web of Science ®Google Scholar
• Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, Lu W, Wan X, Ma D, Xie X. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011; 224:484-95; PMID:21503900; https://doi.org/10.1002/path.2873
   PubMed Web of Science ®Google Scholar
• Liu C, Lin J, Li L, Zhang Y, Chen W, Cao Z, Zuo H, Chen C, Kee K. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells. Sci Rep 2015; 5:7653; PMID:25563170; https://doi.org/10.1038/srep07653
   PubMed Web of Science ®Google Scholar
• Villegas-Ruiz V, Juárez-Méndez S, Pérez-González OA, Arreola H, Paniagua-García L, Parra-Melquiadez M, Peralta-Rodríguez R, López-Romero R, Monroy-García A, Mantilla-Morales A, et al. Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol 2014; 7:1389-401; PMID:24817935
   PubMed Web of Science ®Google Scholar
• Ribeiro J, Sousa H. MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep 2014; 41:1525-31; PMID:24402874; https://doi.org/10.1007/s11033-013-2998-0
   PubMed Web of Science ®Google Scholar
• Shishodia G, Shukla S, Srivastava Y, Masaldan S, Mehta S, Bhambhani S, Sharma S, Mehrotra R, Das BC, Bharti AC. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis. Mol Cancer 2015; 14:116; PMID:26051842; https://doi.org/10.1186/s12943-015-0385-2
   PubMed Web of Science ®Google Scholar
• Shishodia G, Verma G, Srivastava Y, Mehrotra R, Das BC, Bharti AC. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein. BMC Cancer 2014; 14:996; PMID:25539644; https://doi.org/10.1186/1471-2407-14-996
   PubMed Web of Science ®Google Scholar